Overview of the diagnostic value of biochemical markers of liver fibrosis (FibroTest, HCV FibroSure) and necrosis (ActiTest) in patients with chronic hepatitis C

BACKGROUND: Recent studies strongly suggest that due to the limitations and risks of biopsy, as well as the improvement of the diagnostic accuracy of biochemical markers, liver biopsy should no longer be considered mandatory in patients with chronic hepatitis C. In 2001, FibroTest ActiTest (FT-AT),...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Poynard, Thierry, Imbert-Bismut, Françoise, Munteanu, Mona, Messous, Djamila, Myers, Robert P, Thabut, Dominique, Ratziu, Vlad, Mercadier, Anne, Benhamou, Yves, Hainque, Bernard
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2004
Teme:
Research
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC522750/
https://ncbi.nlm.nih.gov/pubmed/15387887
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1476-5926-3-8
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki